<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kumar</surname>
    <given-names>B. K.</given-names>
   </name>
   <name>
    <surname>Sekhar</surname>
    <given-names>K. V. G. C.</given-names>
   </name>
   <name>
    <surname>Kunjiappan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jamalis</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Bala√±a-Fouce</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tekwani</surname>
    <given-names>B. L.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020a</year>). 
  <article-title>Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19</article-title>. 
  <source>Bioorg. Chem.</source>
  <volume>104</volume>,.
  <fpage>104269</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104269</pub-id>
  <pub-id pub-id-type="pmid">32947136</pub-id>
 </mixed-citation>
</ref>
